Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause serious skin problems that need careful management.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Oxidative stress contributes to hair graying and loss as we age.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

The yeast Pityrosporum ovale can cause skin allergies and infections, and antifungal treatments like ketoconazole are effective against it.

Mammals might fail to regenerate not because they lack the right cells, but because of how cells respond to their surroundings, and changing this environment could enhance regeneration.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

FFA's causes may include environmental triggers and genetic factors.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Adult stem cells are important for tissue repair and have therapeutic potential, but more research is needed to fully use them.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.